Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Lidak Pharm. [LDAKA] -- Ignore unavailable to you. Want to Upgrade?

To: Red Dragon who wrote (1067)	6/17/1998 10:29:00 PM
From: luis a. garcia	Respond to of 1115

Well consider that Lidakol is better than acyclovir and penciclovir and safer and cheaper to manufacture and manufacturing is in place ready to go. I'd say because the snafu with the 96 trial in which the placebo was lidakol deactivated except they screwed up and just weakened it therefore no statistical significant was proven at that time. The market is simply waiting on FDA letter of approval. That makes this stock such a great opportunity. That is the trade, if the stock was trading at six dollars etc then it would not be so attractive would it?. Now if that wasn't enough there was the Katz antics which we are all aware of and a lot of goings on which are all going in the right direction and will be untangled in time to maket the lidakol. It is probably the best opportunity in the street. 40% aborted episodes. 1/2 healing time 2 days to cessation of disconfort and pain. This stock can see 1.50 per share based on this one product alone. they have assembled a very savvy board of directors and are looking to move ahead and fill their pipeline with products that can be made ready for market in three years etc. Plus they have a team which has succeeded in bringing off the phase III trial and NDA filing in one years time. That is a good team. the street just is not following this very closely. their loss is our gain. stop pouting and get with it red.. lets make us some money... regards luis